Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
Main Street Capital Corporation issued a press release on August 6, 2026 disclosing its second quarter 2026 financial results, including net investment income of $0.97 per share, distributable net investment income of $1.04 per share, and net asset value of $33.92 per share. The filing explicitly states under Item 2.02 that "the Registrant issued a press release" with "a copy of such press release is attached hereto as Exhibit 99.1," which is the standard disclosure mechanism for quarterly earnings releases.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
Genpact issued a press release on August 6, 2026 announcing financial results for Q2 2026 (three months ended June 30, 2026), disclosing net revenues of $1.343 billion (up 7.1% YoY), net income of $146 million (up 9.8% YoY), and diluted EPS of $0.86 (up 14.7% YoY). The filing explicitly states it is furnished pursuant to Item 2.02 "Results of Operations and Financial Condition," and the press release is attached as Exhibit 99.1. This is a standard quarterly earnings disclosure material to investors.
View raw filing on EDGAR →
8-K
Financial Other
confidence 75%
filed 2026-08-06
Item 7.01
First Guaranty completed the sale of its Texas banking operations (five branches, ~$234 million in deposits, ~$88 million in loans) to Armstrong Bank on July 31, 2026. This is a material divestiture of a business segment, but does not fit the specific `ma_activity` category (which typically covers acquisitions, mergers, or changes of control) or `financial_other` perfectly. The sale is a significant financial transaction affecting the registrant's asset base and geographic footprint, disclosed under Item 7.01 (Regulation FD Disclosure) rather than the more formal Item 1.02 (Unregistered Sales of Equity Securities) or Item 2.01 (Completion of Acquisition or Disposition of Assets), suggesting it may be treated as non-material for filing purposes, though the dollar amounts and operational impact suggest investor relevance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
Keurig Dr Pepper issued a press release on August 6, 2026, announcing Q2 2026 financial results, including net sales of $7.31 billion, diluted EPS of $0.04 (GAAP) and $0.57 (Adjusted), and reaffirmed full-year 2026 guidance. The disclosure is a standard quarterly earnings announcement with detailed segment results and forward guidance, clearly fitting the earnings_release category under Item 2.02.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
This is a straightforward earnings release for Q2 2026 ended July 3, 2026. The Item 2.02 disclosure explicitly states "the Company issued a press release reporting financial results for the second quarter ended July 3, 2026" with the press release attached as Exhibit 99.1. The press release reports net sales of $583 million (3% reported, 5% organic growth), a net loss of $1 million, adjusted EBITDA of $104 million, and reaffirmed full-year 2026 guidance. This is a material disclosure of quarterly financial results typical of Item 2.02 earnings releases.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
PubMatic issued a press release on August 6, 2026 announcing Q2 2026 financial results, disclosing revenue of $78.6 million (up 11% YoY), adjusted EBITDA of $19.6 million (up 38% YoY), and free cash flow of $13.7 million (up 47% YoY), along with forward guidance for Q3 2026.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-08-06
Item 5.02
Steve Pantelick, Chief Financial Officer, announced his planned retirement effective into Q1 2027, with a transition period as senior adviser through July 1, 2027.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
Fox Factory issued a press release on August 6, 2026 disclosing financial results for the second fiscal quarter ended July 3, 2026, including net sales of $358.1 million, net income of $4.1 million ($0.10 per diluted share), and adjusted EBITDA of $45.5 million. The filing explicitly states this is Item 2.02 (Results of Operations and Financial Condition) with the press release attached as Exhibit 99.1, which is the standard format for earnings releases.
View raw filing on EDGAR →
6-K
Periodic Interim
confidence 95%
filed 2026-08-06
This is Genmab's interim report for the six months ended June 30, 2026, furnished as Exhibit 99.1 to the Form 6-K. The document presents consolidated financial statements, revenue breakdowns by product and partner, and operational highlights for H1 2026 compared to H1 2025. Although it includes clinical progress announcements (epcoritamab Phase 3 results, Rina-S data), the core disclosure is a periodic interim financial report covering a six-month period, not a discrete earnings release event. Per the taxonomy guidance, periodic financial reports are deferred for separate processing and classified as `periodic_interim` rather than `earnings_release`.
View raw filing on EDGAR →
8-K
Earnings release
confidence 99%
filed 2026-08-06
Item 2.02
Warner Bros. Discovery disclosed its Q2 2026 quarterly financial results (quarter ended June 30, 2026) via an earnings press release and shareholder letter, including consolidated statements of operations, balance sheets, cash flows, and segment-level revenue and EBITDA analysis.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-08-06
Item 2.02
Ardelyx disclosed Q2 2026 financial results with total product revenue of $118.1 million (31% YoY growth), including IBSRELA revenue of $86.2 million (33% growth) and XPHOZAH revenue of $31.9 million (27% growth), along with a net loss of $16.7 million and revised FY 2026 guidance. The earnings release and presentation were furnished as exhibits and include condensed financial statements and management commentary.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 75%
filed 2026-08-06
Item 1.01
Rush Enterprises amended two material credit facilities with Bank of Montreal: the BMO Revolving Lease and Rental Credit Agreement (extending expiration to December 31, 2029 and removing a $20M CAD accordion feature) and the BMO Wholesale Financing and Security Agreement (extending expiration to December 31, 2029). These amendments to existing direct financial obligations—credit facilities that support the company's lease and rental operations and wholesale financing—constitute material modifications to the company's debt structure and liquidity arrangements, warranting disclosure under Item 1.01.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-06
Item 2.02
CPS Technologies disclosed its financial results for the second quarter ended June 27, 2026 via press releases attached as Exhibits 99.1 and 99.2, reporting revenue of $8.3 million, gross margin of 14.8%, operating loss of $(0.2) million, and net income of $37,747 ($0.00 per diluted share).
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
This is a clear earnings release disclosing Genie Energy's Q2 2026 financial results. The Item 2.02 disclosure explicitly states that "the Registrant distributed over a wire service and posted to the investor relations page of its website...an earnings release announcing its results of operations for the quarter ended June 30, 2026," with the full earnings release furnished as Exhibit 99.1. The release contains consolidated financial highlights, segment results, balance sheet data, and management commentary on operational performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
Ingles Markets disclosed third quarter and nine-month fiscal 2026 financial results, reporting net sales of $1.37 billion and $4.05 billion respectively, net income of $25.9 million and $78.3 million, and earnings per share for both Class A and Class B common stock, along with balance sheet and cash flow information.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
This is a clear earnings release disclosing Guerrilla RF's Q2 2026 financial results, including record quarterly revenue of $8.0 million (up 49% YoY), gross margin expansion to 70.9%, operating income of $1.0 million, and operating cash flow of $2.4 million. The earnings release is furnished as Exhibit 99.1 and represents the principal disclosure under Item 2.02, which is the standard Item for earnings announcements.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
AEMETIS disclosed quarterly and six-month financial results for the periods ended June 30, 2026, via press release. Q2 2026 revenues reached $62.7 million (20% growth), with six-month revenues of $117.3 million, gross profit of $13.5 million, operating income of $5.8 million, and net loss of $9.4 million, along with adjusted EBITDA and segment performance metrics.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
Alpha Pro Tech issued a press release on August 6, 2026 announcing financial results for Q2 and six months ended June 30, 2026, disclosing net sales of $18.7 million (up 12% YoY) and net income of $1.8 million (up 47% YoY). The press release is attached as Exhibit 99.1 and constitutes a standard quarterly earnings disclosure under Item 2.02, with material financial metrics that would affect investor assessment of the company's operating performance.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 95%
filed 2026-08-06
Item 3.01
Accuray received approval to transfer its listing from The Nasdaq Global Select Market to The Nasdaq Capital Market, a lower-tier listing, and was granted a 180-day cure period to meet the $1.00 bid price requirement. This transfer signals failure to satisfy continued listing standards on the higher tier and represents material delisting risk under Item 3.01, as it directly affects the registrant's market standing and investor access.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-06
Item 2.02
This is a standard quarterly earnings release for Q2 2026 (three months ended June 30, 2026) disclosing financial results including revenues of $38.6 million, net loss of $6.3 million, and AFFO of $3.8 million. The press release is furnished as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings disclosures. The filing includes consolidated balance sheets, statements of operations, and cash flow statements typical of quarterly earnings announcements.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-06
Item 2.02
The filing discloses quarterly financial results for Q2 2026 (ended June 30, 2026) through a press release attached as Exhibit 99.1. The Item 2.02 section explicitly states "the Company announced certain financial and operational results for the fiscal quarter ended June 30, 2026," and the press release presents revenue ($0.4M), GAAP net loss ($24.7M), non-GAAP net loss ($19.4M), cash position ($101.6M), and operating cash burn ($18.7M), along with business updates on clinical trials and product development. This is a standard quarterly earnings announcement.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-06
Item 2.02
ParkerVision issued a press release on August 6, 2026 disclosing financial and operating results for the six months ended June 30, 2026, including net loss of $1.4 million (vs. $5.4 million prior year), cash position of $2.5 million, and detailed balance sheet and cash flow statements. This is a standard earnings release disclosure under Item 2.02, material to investors assessing the company's financial condition and operational performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
This is a clear earnings release disclosing Kingsway Corporation's financial results for Q2 2026 and the six-month period ended June 30, 2026. The press release reports consolidated revenue of $39.4 million (27.6% increase), net income of $0.2 million, and adjusted EBITDA of $5.2 million, with segment-level performance metrics for KSX and Extended Warranty. The filing is furnished under Item 2.02 (Results of Operations and Financial Condition) with the press release attached as Exhibit 99.1, which is the standard format for earnings disclosures.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
This is a clear earnings release disclosing Q2 2026 financial results for Apyx Medical Corporation. The filing explicitly states under Item 2.02 that the company "issued a press release reporting on its results of operations for the second quarter ended June 30, 2026," with the press release attached as Exhibit 99.1. The disclosure includes detailed financial statements (condensed consolidated statements of operations and balance sheets), revenue by segment and geography, net loss per share, and full-year 2026 guidance reaffirmation—all hallmarks of a quarterly earnings announcement.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
This is a clear earnings release disclosing quarterly and nine-month financial results for Natural Grocers by Vitamin Cottage. The Item 2.02 filing explicitly states the company "issued a press release announcing its financial results for the three and nine months ended June 30, 2026," with the press release attached as Exhibit 99.1. The exhibit contains detailed consolidated statements of income, balance sheets, and management commentary on operating results, all hallmarks of a standard earnings release.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-08-06
Item 2.01
Hydrofarm completed the sale of Aurora Peat Products ULC to Raven Holdings LLC for $16 million on July 31, 2026. The proceeds were applied to reduce outstanding debt. This significant disposition materially affects the company's asset base, debt structure, and operating footprint.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-06
Item 2.02
This is a standard quarterly earnings release for the period ended June 30, 2026, disclosing financial results including R&D expenses ($3.1M for Q2 2026 vs. $1.1M for Q2 2025), G&A expenses ($1.2M vs. $1.2M), and net loss ($4.1M vs. $2.2M). The filing includes consolidated statements of operations and balance sheets, along with a business update on the lead clinical candidate PH-762. The Item 2.02 disclosure and attached press release (Exhibit 99.1) are characteristic of an earnings_release event.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-06
The 8-K discloses Vaxart's financial results for Q2 2026 via a press release (Exhibit 99.1) filed under Item 2.02 (Results of Operations and Financial Condition). The filing includes condensed consolidated balance sheets, statements of operations, revenue of $27.2M, net loss of $13.5M, and cash runway guidance into Q2 2027. This is a standard quarterly earnings disclosure material to investors assessing the company's financial condition and operational performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
This is a clear earnings release disclosing Puma Biotechnology's financial results for Q2 2026 ended June 30, 2026. The filing explicitly states "On August 6, 2026, Puma Biotechnology, Inc. issued a press release announcing its financial results for the second quarter ended June 30, 2026" and includes detailed GAAP and non-GAAP net income, revenue figures ($56.5M total revenue, $8.2M net income), and updated full-year 2026 guidance. The press release is furnished as Exhibit 99.1 and is typical of Item 2.02 earnings disclosures.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
PDF Solutions disclosed Q2 2026 financial results on August 6, 2026, reporting quarterly revenues of $61.5 million (up 19% year-over-year), GAAP diluted EPS of $0.10, non-GAAP diluted EPS of $0.27, and ending backlog of $270.7 million.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
This is a clear earnings release disclosing Friedman Industries' first quarter financial results for the period ended June 30, 2026. The press release, furnished as Exhibit 99.1, reports net earnings of $12.8 million (up from $5.0 million year-over-year), sales of $240.0 million (up 78% YoY), and record quarterly sales volume. The disclosure includes detailed financial statements, segment performance, and forward-looking guidance, all hallmarks of a quarterly earnings announcement under Item 2.02.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
This is a clear earnings release disclosing Bimini Capital Management's consolidated results of operations for the six- and three-month periods ended June 30, 2026. The filing includes net income of $0.4 million ($0.04 per share) for Q2 2026 and $1.2 million ($0.12 per share) for the six-month period, along with detailed financial statements, portfolio metrics, and management commentary. The press release is attached as Exhibit 99.1 and incorporated by reference under Item 2.02, which is the standard Item for earnings disclosures.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-08-06
Item 1.01
Pulse Biosciences entered into an equity distribution agreement with Mizuho Securities on August 6, 2026, authorizing the sale of up to $75 million in common stock through an "at the market" offering under Rule 415. This is a dilutive equity issuance that provides the company with a capital-raising mechanism and would materially affect existing shareholders through potential dilution. The substantial offering size and explicit authorization to sell shares make this a material capital event.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
Tandem Diabetes Care issued a press release on August 6, 2026 announcing its financial results for the quarter ended June 30, 2026, disclosing Q2 2026 sales of $254.6 million, gross margin of 57%, operating loss of $13.8 million, and net loss of $21.2 million, along with 2026 full-year financial guidance. This is a standard quarterly earnings release furnished as Exhibit 99.1 under Item 2.02, which is material to investors assessing the company's financial performance and trajectory.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
This is a clear earnings release for Q2 2026 ended June 30, 2026. Item 2.02 explicitly discloses financial results including revenue ($203.3M, up 19% YoY), operating loss, net loss, and adjusted EBITDA, with forward guidance for Q3 and full-year 2026. The press release is furnished as Exhibit 99.1 and includes detailed financial statements and reconciliations of non-GAAP measures, which is the standard format for earnings disclosures under Item 2.02.
View raw filing on EDGAR →
8-K
Earnings release
confidence 99%
filed 2026-08-06
Item 2.02
Twilio issued a press release on August 6, 2026 announcing its financial results for the quarter ended June 30, 2026, disclosing Q2 2026 revenue of $1.50 billion (up 22% YoY), GAAP net income per share of $6.68, and raising full-year 2026 guidance. This is a standard quarterly earnings release furnished under Item 2.02 and attached as Exhibit 99.1, which is material to investors assessing the company's financial performance and outlook.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-06
Item 2.02
Cartesian Therapeutics announced its financial results for the quarter ended June 30, 2026, via press release furnished as Exhibit 99.1. The disclosure includes quarterly financial metrics (R&D expenses of $20.4M, G&A expenses of $8.7M, net income of $15.8M), cash position ($149.3M), and operational updates on clinical trials and partnerships. This is a standard quarterly earnings release under Item 2.02.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
Teads Holding Co. issued a press release on August 6, 2026 announcing financial results for the quarter ended June 30, 2026, disclosing revenue of $284.6 million (down 17% YoY), net loss of $42.5 million (compared to $14.3 million loss in prior year), and suspending full-year 2026 guidance. This is a standard quarterly earnings release with detailed financial metrics, business highlights, and forward-looking statements, filed under Item 2.02 (Results of Operations and Financial Condition).
View raw filing on EDGAR →
8-K
Earnings release
confidence 99%
filed 2026-08-06
Item 2.02
This is a clear earnings release for Q2 2026 (quarter ended June 30, 2026) issued on August 6, 2026. The press release discloses key financial metrics including SaaS and license revenue of $188.8 million (up 11.1%), GAAP net income of $24.2 million, non-GAAP adjusted EBITDA of $57.7 million, and updated full-year 2026 guidance. The filing is properly classified under Item 2.02 (Results of Operations and Financial Condition) and the press release is furnished as Exhibit 99.1, which is the standard format for earnings disclosures.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
BRC Group Holdings issued a press release on August 6, 2026 reporting financial results for the fiscal quarter and six months ended June 30, 2026. The disclosure includes detailed financial metrics (net income of $18.5M for Q2 and $229.8M year-to-date, revenues of $239.1M and $591.2M respectively, Adjusted EBITDA of $61.3M and $323.4M), segment performance, and management commentary. This is a standard quarterly earnings release attached as Exhibit 99.1, typical of Item 2.02 disclosures.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
This is a clear earnings release for Q2 2026 (quarter ended June 30, 2026) filed on August 6, 2026. The Item 2.02 disclosure announces quarterly GAAP earnings of $0.01 per diluted share and Distributable Earnings of $0.40 per diluted share, with detailed financial statements and segment results attached as Exhibit 99.1. The press release includes key operational metrics (invested $6.7 billion, record total assets of $31.8 billion) and management commentary, which is typical of earnings releases for REITs.
View raw filing on EDGAR →
8-K
Earnings release
confidence 99%
filed 2026-08-06
Item 2.02
Dropbox issued a press release on August 6, 2026 announcing its Q2 2026 financial results, including revenue of $631.5 million (0.9% YoY growth), GAAP operating margin of 26.1%, Non-GAAP operating margin of 39.7%, and unlevered free cash flow of $283.5 million.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-08-06
Item 2.02
Expensify issued a press release on August 6, 2026 announcing financial results for the quarter and year ended June 30, 2026, including revenue of $33.9 million (down 5% YoY), net loss of $3.9 million (improved from $8.8 million), and free cash flow of $6.4 million, with detailed financial highlights and forward guidance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
Cloudflare disclosed Q2 2026 financial results via press release, reporting revenue of $696.1 million (36% YoY growth), GAAP net loss of $170.0 million, non-GAAP net income of $107.8 million, and forward guidance for Q3 and full-year 2026.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 92%
filed 2026-08-06
The 6-K discloses multiple executive and board changes effective August 2, 2026: appointment of Mr. Yongxin Su as director and Co-Chief Executive Officer, Ms. Bihua Liu as director and Co-Chief Financial Officer, Mr. Lei Yao as independent director and nominating committee chair, and Mr. Shipu Huang as independent director. While two directors also resigned (Zhang and Qian), the principal disclosed actions are the four new appointments to key governance and executive roles, making this an exec_appointment event. The appointments of two Co-CEOs and a Co-CFO are material to investor assessment of leadership and control.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-08-06
EX-99.1
This is a press release disclosing Orion Digital's Q2 2026 financial results, including revenue of $16.9 million, Adjusted EBITDA of $3.3 million (up 115% sequentially and 70% year-over-year), and key operational metrics such as Wealth AUM growth of 18% to $545.3 million. The document explicitly states "Orion Digital reports Q2 2026 Results" and provides comprehensive financial performance data, management commentary, and forward guidance, which are hallmarks of an earnings release. This is material to investors as it discloses significant earnings improvements and operational milestones including the commercial launch of Intelligent Investing.
View raw filing on EDGAR →
8-K
Exec departure
confidence 98%
filed 2026-08-06
Item 5.02
Shannon Kinney, serving as Executive Vice President, Chief Administrative Officer, General Counsel, and Corporate Secretary, notified the Company on August 2, 2026 of her resignation effective August 31, 2026. This is a clear departure of a senior officer holding multiple critical roles (legal, compliance, and corporate governance functions). The departure of a C-suite executive with broad responsibilities is material to investors.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 98%
filed 2026-08-06
Item 8.01
Knight-Swift's board declared a quarterly cash dividend of $0.20 per share, payable to stockholders of record on September 4, 2026, with payment expected on September 21, 2026. This is a straightforward dividend distribution announcement disclosed under Item 8.01 (Other Events), consistent with the company's established quarterly dividend policy. The disclosure is material as it affects shareholder returns and capital allocation decisions.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-06
Item 2.02
This is a clear earnings release for Q2 2026 ended June 30, 2026. The Item 2.02 disclosure announces quarterly financial results including net loss of $13 million, diluted EPS of ($1.53), revenue of $283 million (up 15% YoY), and servicing metrics. The press release is attached as Exhibit 99.1 and contains detailed operating results, business highlights, and forward guidance—all hallmarks of a standard quarterly earnings announcement.
View raw filing on EDGAR →
6-K
Earnings release
confidence 98%
filed 2026-08-06
EX-99.5
This is a press release announcing Real Brokerage Inc.'s second quarter 2026 financial results, dated August 6, 2026. The exhibit discloses Q2 2026 revenue of $700.6 million (30% growth), net loss of $8.0 million, and Adjusted EBITDA of $27.6 million (38% growth), along with detailed financial statements and operational metrics. This is a discrete earnings announcement, not a periodic financial report filing, and is material to investors assessing the company's financial performance.
View raw filing on EDGAR →